References
- Aldershvile J, Ocholm M, Tagjensen V, Mordt F, Nelson JO. Hepatitis B virus infection among household contacts of patients with acute HBsAg positive hepatitis. Infection 1981; 9: 164–6.
- Arankale VA, Chadha MS, Banerjee K. Necessity to vaccinate spouses of hepatitis B patients and carriers [Letter]. JAPI (Journal of Association of Physicians of India) 1990; 38: 517.
- Steven CE, Bearely RP, Tsui J, Leew C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 298: 771–4.
- Dhorje DP, Pavri KM, Prasad SR, Sehgal A, Phule DM. Horizontal transmission of hepatitis B virus infection in household contacts in Pune, India. J Med Virol 1985; 16: 183–9.
- Zuckerman AJ. Prevention of primary liver cancer by immunization. N Engl J Med 1997; 336: 1906–7.
- Szmuness W, Stevens CE, Zanea P, Marly EJ, Kellnee A. A controlled clinical trial of the efficacy of hepatitis B vaccine (Hepavax B). A final report. Hepatology 1981; 1: 377–85.
- Thompson S, Ruft TA. Hepatitis B vaccination. What are the current international recommendations. Clin Immunother 1995; 3: 15–26.
- Zahradnik JM, Heiberg D, Hollinger FB. Hepatitis B vaccine immune responses in children from families with an HBsAg carrier. Vaccine 1985; 3: 407–13.
- Koto Y, Miyamori M, Unoura M, Ohmiyo R, Tanaka N, Kobayashi K, et al. Clinical trials of hepatitis B vaccine in the families of HBV carriers. J Clin Gastroenterol 1986; 8: 545–9.
- Lok ASF, Lai CL, Chee PWO. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implication in hepatitis B vaccination programs. Hepatology 1988; 8: 766–70.
- Sampliner RE. Significance of isolated antibody to hepatitis B core antigen, determined by immune response to hepatitis B vacciantion. JAMA 1987; 258: 1193–5.
- Chan CY, Lee SD, Tsai YT, Lo KJ. Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol 1995; 10: 192–7.
- Craxi A, Vinci M, Almario P, Pagliaro L. Hepatitis B vaccination of relatives of hepatitis B virus DNA positive carriers: an experience with plasma derived vaccine. Eur J Epidemiol 1989; 5: 65–9.
- Guptan RC, Thakur V, Sarin SK. Hepatitis B in high risk groups in India. In: Sarin SK, Singhal AK, eds. Hepatitis B in India: Problems and prevention. New Delhi: CBS, 1996: 39–50.
- Thakur V, Guptan RC, Malhotra V, Sarin SK. Prevalence of hepatitis B infection and disease in contacts of chronic liver disease patients: analysis of HBeAg positive versus HBeAg negative patients. Hepatology 1998; 28: 483A.
- Guptan RC, Thakur V, Sarin SK, Banerjee K, Khandekar P. Frequency and clinical profile of precore and surface hepatitis B mutants in Asian Indians with chronic liver disease. Am J Gastroenterol 1996; 91: 1312–7.
- Sarin SK. Clinical spectrum of hepatitis B in India. In: Sarin SK, Singhal AK, eds. Hepatitis B in India: Problems and prevention. New Delhi: CBS, 1996: 51–63.
- Draelos M, Morgan T, Schifman RB, Sampliner RE. Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination. JAMA 1987; 258: 1193–5.
- Lai CL, Wong BCU, Yeoh EK, Lin WL, Chang WK, Lin HJ. Five year follow up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma derived vaccine in children: immunogenicity and anamnestic responses. Hepatology 1993; 18: 763–7.
- Pal S, Driss F, Michal ML, Nalpas B, Berthelat P, Brechal C. Specific vaccine therapy in chronic hepatitis B infection. Lancet 1994; 344: 342.